Lifecore Biomedical, Inc. (LFCR) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Lifecore Biomedical, Inc. (LFCR:NASDAQ), powered by AI.

Current Price
$5.64
P/E Ratio
-5.1
Market Cap
196M
Sector
Healthcare
What is the Lifecore Biomedical, Inc. stock price forecast?

Lifecore Biomedical, Inc. is currently trading at $5.64. View real-time AI analysis on Alpha Lenz.

What is Lifecore Biomedical, Inc. insider trading activity?

View the latest insider trading data for Lifecore Biomedical, Inc. on Alpha Lenz.

What is Lifecore Biomedical, Inc.'s P/E ratio?

Lifecore Biomedical, Inc.'s P/E ratio is -5.1.

Lifecore Biomedical, Inc.

NASDAQ · LFCR
$5.64-0.01(-0.18%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Lifecore Biomedical, Inc.'s future dividend policy...
Alpha Chat Insight

Lifecore Biomedical, Inc. has a P/E of -5.1. Compare its valuation with peers.

Ask for details

Company Overview

Lifecore Biomedical Inc. is a prominent entity in the biotechnology sector, primarily engaged in the manufacture and development of high-quality biomedical products. The company specializes in the production of hyaluronan and other polysaccharide-based products for medical applications. These biomaterials are crucial in various medical fields, including ophthalmology, orthopedics, and general surgery, thanks to their biocompatibility and multifunctional characteristics. Lifecore Biomedical Inc.'s expertise in manufacturing and formulation is underscored by its integration with the pharmaceutical and health industries, where its products are utilized in drug delivery systems and surgical applications. Established with a commitment to quality and innovation, the company plays a significant role in advancing medical technology and improving patient outcomes globally. Its presence in the market underscores the critical interface between leading-edge biotechnology and practical health applications, making it a key player in the advancement of medical treatments and technologies.

CEOMr. Paul Josephs
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees406

Company Statistics

FY 2025

Profile

$196.38MMarket Cap
N/ARevenue
0.00Shares Out
406Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

-5.07P/E
146.99P/B
1.52EV/Sales
-87.40EV/EBITDA
-14.42P/FCF

Growth (CAGR)

5.02%Rev 3Yr
-4.24%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

N/AROA
N/AROE
N/AROIC

Financial Health

$17.47MCash & Cash Equivalents
$228.91MNet Debt
-1734.82%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Lifecore Biomedical, Inc. (ticker: LFCR) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 406 employees. Market cap is $196M.

The current price is $5.64 with a P/E ratio of -5.07x and P/B of 146.99x.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Lifecore Biomedical, Inc. (LFCR) Stock Forecast 2026 $5.64 — Price, Financials & Analyst Targets | Alpha Lenz